DalsnaFinance

Steris $STE

Health Care · Health Care Equipment · NYSE/NASDAQ

S&P 500 Russell 1000 Ireland
Create a scorecard
$225.18
+3.21 (+1.45%)
As of Oct 20, 2026, 6:15 PM EDT
Price history
Loading chart…

Key facts

52-week range (closes)
$199.40 – $268.65 Lowest close Jun 17, 2026, highest Jan 16, 2026; 251 daily closes to Oct 13, 2026 from Dalsna Finance's price archive
Fiscal year ends
March Fiscal 2026 ended Mar 31, 2026, from SEC filings
In the S&P 500 since
Dec 23, 2019, replacing Affiliated Managers Group (AMG), TripAdvisor (TRIP) and Macerich (MAC) · Market capitalization changes. · All S&P 500 changes

Steris (STE) is trading up at $225.18 (+1.45%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.

Steris revenue & net income history (FY2017–FY2026)

RevenueNet incomeNet margin (right axis, %)
$5.94B$2.97B$0FY2017 revenue: $2.61BFY2017 net income: $110.0M · Net margin 4.2%'17FY2018 revenue: $2.62BFY2018 net income: $290.9M · Net margin 11.1%'18FY2019 revenue: $2.78BFY2019 net income: $303.7M · Net margin 10.9%'19FY2020 revenue: $3.03BFY2020 net income: $407.7M · Net margin 13.5%'20FY2021 revenue: $3.11BFY2021 net income: $397.4M · Net margin 12.8%'21FY2022 revenue: $4.22BFY2022 net income: $243.9M · Net margin 5.8%'22FY2023 revenue: $4.54BFY2023 net income: $107.0M · Net margin 2.4%'23FY2024 revenue: $5.14BFY2024 net income: $378.2M · Net margin 7.4%'24FY2025 revenue: $5.46BFY2025 net income: $614.6M · Net margin 11.3%'25FY2026 revenue: $5.94BFY2026 net income: $782.3M · Net margin 13.2%'260%5%10%15%FY2017 net margin: 4.2%FY2018 net margin: 11.1%FY2019 net margin: 10.9%FY2020 net margin: 13.5%FY2021 net margin: 12.8%FY2022 net margin: 5.8%FY2023 net margin: 2.4%FY2024 net margin: 7.4%FY2025 net margin: 11.3%FY2026 net margin: 13.2%
Steris annual financial statements
FY2017Mar 2017FY2018Mar 2018FY2019Mar 2019FY2020Mar 2020FY2021Mar 2021FY2022Mar 2022FY2023Mar 2023FY2024Mar 2024FY2025Mar 2025FY2026Mar 2026
Income statement
Revenue$2.61B$2.62B$2.78B$3.03B$3.11B$4.22B$4.54B$5.14B$5.46B$5.94B
Growth (year over year)—+0.3%+6.2%+8.9%+2.5%+35.9%+7.4%+13.3%+6.2%+8.7%
Gross profit$1.03B$1.09B$1.17B$1.32B$1.34B$1.88B$1.98B$2.22B$2.40B$2.63B
Gross margin39.3%41.7%42.2%43.6%43.2%44.6%43.7%43.2%44.0%44.2%
Operating income$226.2M$399.9M$411.0M$537.0M$548.4M$477.8M$791.1M$836.1M$866.6M$1.10B
Operating margin8.7%15.3%14.8%17.7%17.6%11.3%17.4%16.3%15.9%18.6%
Net income$110.0M$290.9M$303.7M$407.7M$397.4M$243.9M$107.0M$378.2M$614.6M$782.3M
Net margin4.2%11.1%10.9%13.5%12.8%5.8%2.4%7.4%11.3%13.2%
EPS (diluted)$1.28$3.39$3.55$4.76$4.63$2.48$1.07$3.81$6.20$7.93
Balance sheet
Cash and equivalents$282.9M$201.5M$220.6M$319.6M$220.5M$348.3M$208.4M$207.0M$171.7M$439.6M
Total assets—$5.20B$5.07B$5.44B$6.57B$11.4B$10.8B$11.1B$10.1B$10.7B
Total liabilities—$1.98B$1.89B$2.02B$2.68B$4.88B$4.73B$4.75B$3.53B$3.54B
Long-term debt—$1.32B$1.18B$1.15B$1.65B$2.95B$3.02B$3.12B$1.92B$1.81B
Shareholders' equity$2.81B$3.21B$3.18B$3.41B$3.88B$6.53B$6.08B$6.30B$6.60B$7.18B
Cash flow
Operating cash flow$424.1M$457.6M$539.5M$590.6M$689.6M$684.8M$756.9M$973.3M$1.15B$1.34B
Capital expenditure$172.9M$165.5M$189.7M$214.5M$239.3M$287.6M$362.0M$360.3M$370.1M$369.0M
Free cash flow$251.2M$292.2M$349.8M$376.0M$450.4M$397.2M$395.0M$613.0M$778.0M$972.4M
Dividends paid$93.2M$102.9M$112.5M$123.0M$133.8M$163.2M$183.5M$200.6M$219.9M$241.8M
Share buybacks$97.5M$65.5M$81.5M$51.2M$14.6M$55.8M$308.6M$11.8M$211.3M$235.5M

From Steris's 10-K and 10-Q filings with the SEC; its fiscal year ends in March. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

Steris vs the Health Care sector and the S&P 500

Steris's latest reported figures next to the median of the other 59 S&P 500 Health Care companies and of the other 502 S&P 500 companies; each median is taken over the companies with a comparable figure (counts in the footnote). A median is the middle value, not an average, so one very large company does not move it.

Steris compared with the median Health Care company and the median S&P 500 company
MeasureSterisHealth Care (59 other S&P 500 companies)S&P 500 (502 other companies)
Revenue growth, latest fiscal year+8.7%+7.1%+7.0%
Net margin, latest fiscal year13.2%12.9%12.9%
Dividend per share, latest fiscal year$2.46$2.45$2.40
Share price change, 1 year−7.0%+22.8%+7.5%

Steris: fiscal year ended March 2026, from its 10-K and 10-Q filings with the SEC. Medians computed October 20, 2026 from each company's latest annual filing (fiscal years ending between July 2025 and September 2026) and our price archive. Prices for every company, Steris included, are the last regular-session prices of October 20, 2026; the 1-year change compares that price with each company's last close on or before October 20, 2025. Net margin and price change are our calculations from reported figures. Each median counts only the companies with a comparable figure (sector / S&P 500): revenue growth 59/496, net margin 59/496, dividend per share 32/349, 1-year price change 59/488; the reasons below can overlap. 14 are left out of the price figure because our archive holds no comparable close for them; dividend medians are among the 32 sector and 349 S&P 500 companies reporting a per-share dividend. The S&P 500 price figure is the middle company's change, not the index's return.

About Steris

Steris plc is an American-Irish-based medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, and has been legally registered in Dublin, Ireland, for tax purposes since 2018. Previously the company was registered in the United Kingdom from 2014 to 2018.

Source: Wikipedia — Steris

Headquarters
Dublin, Ireland From SEC filings, Oct 2026

Recent News (17)

More Health Care stocks

Browse all companies →